UBS AM’s Apogee Therapeutics APGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.39M | Buy |
55,062
+19,336
| +54% | +$840K | ﹤0.01% | 2070 |
|
|
2025
Q1 | $1.33M | Buy |
35,726
+3,465
| +11% | +$129K | ﹤0.01% | 2185 |
|
|
2024
Q4 | $1.46M | Buy |
32,261
+20
| +0.1% | +$906 | ﹤0.01% | 2190 |
|
|
2024
Q3 | $1.89M | Sell |
32,241
-2,162
| -6% | -$127K | ﹤0.01% | 2063 |
|
|
2024
Q2 | $1.35M | Buy |
+34,403
| New | +$1.35M | ﹤0.01% | 2209 |
|